Table 5. Vaccine effectiveness at preventing cases of COVID-19 by vaccine manufacturer and vaccination status for both test-negative analysis results.

	Manufacturer	Vaccination status	Cases COVID-19 test positive	Controls COVID-19 test negative	OR (95% CI)	aOR (95% CI)
Test-negative analysis based on COVID-19 test results	Pfizer	Fully or partially vaccinated	80	732	0.06 (0.05, 0.09)	0.06 (0.04, 0.07)
		Unvaccinated	571	345
	Moderna	Fully or partially vaccinated	37	611	0.04 (0.03, 0.05)	0.03 (0.02, 0.04)
		Unvaccinated	571	345
	Janssen	Fully or partially vaccinated	7	93	0.05 (0.02, 0.09)	0.04 (0.02, 0.09)
		Unvaccinated	571	345

	Manufacturer	Vaccination status	Cases COVID-19 test positive with >1 moderate to severe COVID symptoms	Controls COVID-19 test positive without moderate to severe COVID symptoms and COVID-19 test negative	OR (95% CI)	aOR (95% CI)
Test-negative analysis based on COVID-19 test results and requiring at least one moderate to severe symptom	Pfizer	Fully or partially vaccinated	30	620	0.35 (0.23, 0.52)	0.38 (0.24, 0.58)
		Unvaccinated	108	769
	Moderna	Fully or partially vaccinated	9	495	0.13 (0.07, 0.26)	0.14 (0.07, 0.28)
		Unvaccinated	108	769
	Janssen	Fully or partially vaccinated	3	83	0.26 (0.08, 0.83)	0.35 (0.11, 1.15)
		Unvaccinated	108	769